🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
60 patients of radiological, biopsy proven advanced HCC (Hepatocellular car...
Status
Completed
Location
Institute of Liver & Biliary Sciences
Start Date
2014-10-01
Trial ID
NCT02259647
Determine time-to-progression (TTP) for an escalating dose schedule for sub...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2007-12
Trial ID
NCT00854620
Treatments Being Tested
The purpose of this study is to evaluate the combination of Revlimid® (lena...
Status
Terminated
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2011-05
Trial ID
NCT01348503
Treatments Being Tested
Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Status
Unknown
Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Start Date
2014-12
Trial ID
NCT02794337
The goal of this clinical research study is to learn if 5-azacitidine and s...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-02-06
Trial ID
NCT02196857
Treatments Being Tested
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking the enz...
Status
Completed
Location
Tom Baker Cancer Centre - Calgary
Start Date
2004-08-10
Trial ID
NCT00093457
Treatments Being Tested
To evaluate efficacy and safety of sorafenib versus placebo in the adjuvant...
Status
Completed
Location
Multiple Locations
Start Date
2008-08-15
Trial ID
NCT00692770
Treatments Being Tested
The purpose of this study is to evaluate the effect of combining a new inve...
Status
Terminated
Location
Emory University Winship Cancer Institute
Start Date
2011-03
Trial ID
NCT01334710
Treatments Being Tested
RATIONALE: Sorafenib and everolimus may stop the growth of cancer cells by ...
Status
Completed
Location
Holden Comprehensive Cancer Center at University of Iowa
Start Date
2007-08-29
Trial ID
NCT00474929